I would be very surprise if with continues very go

I would be very surprise if with continues very good response in cancers this will not be approve in 2020...
Probably approved with confirmatory phase , but this makes no difference to us or patients ..

Those are very deadly cancers and FDA know that , and they know by now this medicine is without one serious side effects .


This patients dying sometimes within months after diagnosis .,

Let’s see what FDA will do ..